Regeneron Pharmaceuticals Inc (REGN)
1023.75
-20.91
(-2.00%)
USD |
NASDAQ |
Jul 03, 12:59
1022.02
-1.73
(-0.17%)
After-Hours: 13:59
Regeneron Pharmaceuticals Research Expense (Quarterly)
Research Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research Expense (Quarterly) Data
Date | Value |
---|
Research and Development Expense Definition
Research and Development Expenses (R&D) are the costs a business incurs while researching or developing new products or services. R&D expenses often vary by sector, with certain sectors, such as technology or health care, generally incurring higher R&D expenses when creating new products. The Research and Development Expense numbers in YCharts are taken from a line item included in the company’s income statement
Research Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research Expense (Quarterly) Benchmarks
Vertex Pharmaceuticals Inc | -- |
Amgen Inc | -- |
Eli Lilly and Co | -- |
Pfizer Inc | -- |
Moderna Inc | -- |